NCT00418275View on ClinicalTrials.gov

Safety Study of a Recombinant Human Plasminogen Activator to Treat Acute Ischemic Stroke.

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2001

Study Completion Date

June 30, 2004

Conditions
Cerebrovascular Accident
Interventions
GENETIC

Recombinant Human Plasminogen Activator (HTUPA)

Trial Locations (1)

112

Veterans General Hospita-lNeurological Institute, No. 201, Sec. 2, Shih-Pai Road

Sponsors

Lead Sponsor

Global Biotech
All Listed Sponsors
lead

Global Biotech

INDUSTRY